Literature DB >> 23177278

Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.

Yusuke Takahashi1, Genichiro Ishii, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Kanji Nagai.   

Abstract

INTRODUCTION: Adenocarcinoma of the lung is a morphologically heterogeneous group of tumors which includes a variable portion of different histologic subtype components: lepidic growth (LG), and acinar, papillary and solid subtypes. Among these, LG is a non-invasive component which is one of the major histological subtypes in small-sized adenocarcinoma (2 cm or less). However, in large adenocarcinomas (3-5 cm in size), the clinicopathological significance of LG components remains unclear.
METHODS: A series of 135 lung adenocarcinomas 3-5 cm in size, without lymph node involvement, were reviewed and classified according to their percentage of LG components. We examined the correlation between the percentage of LG components and clinicopathological factors of these tumors.
RESULTS: There were 41 (30.4%) tumors with 50% or more LG (LG-predominant group). Female gender (p=0.039), smoking history of <20 pack-years (p=0.039), absence of pleural invasion (p=0.003), and absence of vascular invasion (p<0.001) were significantly more frequently observed in the LG-predominant group. LG-predominant tumors showed a significantly higher percentage of non-cancerous cell collapse area to tumor area compared with non-LG predominant tumors (p<0.001). The outcome of the LG-predominant type patients was significantly better than that of the non-LG predominant type patients in both recurrence-free survival (p<0.001) and overall survival (p<0.001). Multivariate analysis showed that LG-predominant tumor to be an independent favorable prognostic factor (HR=0.285, 95% confidence interval: 0.148-0.547, p=0.014).
CONCLUSION: Node-negative LG-predominant adenocarcinomas of 3-5 cm in size showed less invasiveness compared to non-LG predominant tumors. And LG-predominant type patients had excellent surgical outcome.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23177278     DOI: 10.1016/j.lungcan.2012.10.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  15 in total

1.  Intraoperative subtyping of lung adenocarcinoma: an unmet need.

Authors:  Nurlan Aliyev; Yusuke Takahashi; Shaohua Lu; Marissa Mayor; Prasad S Adusumilli
Journal:  Transl Cancer Res       Date:  2016-04-19       Impact factor: 1.241

2.  The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.

Authors:  Kazunori Hata; Junji Yoshida; Hibiki Udagawa; Hiroko Hashimoto; Satoshi Fujii; Tomoyuki Hishida; Takeshi Kuwata; Keiju Aokage; Motohiro Kojima; Atsushi Ochiai; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-08       Impact factor: 4.553

3.  Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy.

Authors:  Yusuke Takahashi; Takashi Eguchi; Sarina Bains; Prasad S Adusumilli
Journal:  Ann Transl Med       Date:  2016-02

4.  Preponderance of High-Grade Histologic Subtype in Autologous Metastases in Lung Adenocarcinoma.

Authors:  Yusuke Takahashi; Takashi Eguchi; Shaohua Lu; Robert J Downey; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

5.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.

Authors:  Jonathan E Leeman; Andreas Rimner; Joseph Montecalvo; Meier Hsu; Zhigang Zhang; Donata von Reibnitz; Kelly Panchoo; Ellen Yorke; Prasad S Adusumilli; William Travis; Abraham J Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-29       Impact factor: 7.038

6.  The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.

Authors:  Trond-Eirik Strand; Hans Rostad; Erik H Strøm; Philip Hasleton
Journal:  Diagn Pathol       Date:  2015-07-09       Impact factor: 2.644

7.  Significant correlation between urinary N(1), N(12)-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer.

Authors:  Yusuke Takahashi; Hirotoshi Horio; Koji Sakaguchi; Kyoko Hiramatsu; Masao Kawakita
Journal:  BMC Cancer       Date:  2015-02-18       Impact factor: 4.430

8.  Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.

Authors:  Soohyun Hwang; Joungho Han; Misun Choi; Myung-Ju Ahn; Yong Soo Choi
Journal:  J Pathol Transl Med       Date:  2016-10-16

9.  Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance.

Authors:  Yusuke Takahashi; Takashi Eguchi; Koji Kameda; Shaohua Lu; Raj G Vaghjiani; Kay See Tan; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Oncotarget       Date:  2018-11-06

10.  An effective inflation treatment for frozen section diagnosis of small-sized lesions of the lung.

Authors:  Zhenzhen Xiang; Jie Zhang; Jikai Zhao; Jinchen Shao; Lanxiang Zhao; Ye Zhang; Gang Qin; Jie Xing; Yuchen Han; Keke Yu
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.